Quantcast
Last updated on April 17, 2014 at 13:16 EDT

Latest Phacoemulsification Stories

2011-09-14 05:00:00

ALISO VIEJO, Calif. and MUNICH, Sept. 14, 2011 /PRNewswire/ -- Bausch + Lomb, the global leader in eye health, and Technolas(TM) Perfect Vision GmbH (TPV), a leading ophthalmology laser company, plan to introduce the VICTUS(TM) Femtosecond Laser Platform at the upcoming XXIX Congress of the European Society of Cataract and Refractive Surgeons (ESCRS 2011). The VICTUS platform is a first-of-its-kind technology, capable of supporting cataract, refractive and therapeutic procedures in a...

2011-09-06 09:00:00

Worldwide, cataract surgeriesâ”arguably the safest, most frequently performed, and most effective surgeries performedâ”are expected to number 19 million in 2011, and this number will grow briskly, at more than three times the rate of population growth, as populations age and access to more advanced health care increases in rapidly emerging markets and other developing nations. Market Scope has announced the availability of its full suite of six 2011...

2011-08-22 09:30:00

SANTA ANA, Calif., Aug. 22, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs) with the European CE Mark of Healon EndoCoat OVD. The clear, viscous, low molecular weight dispersive OVD is intended for use as a surgical aid in cataract extraction, intraocular lens (IOL) implantation, corneal transplantation, and glaucoma filtration surgery. Healon EndoCoat OVD's formula protects and...

2011-08-16 06:45:00

Cataract Diagnoses Expected to Rise by 2017 Across Europe VANCOUVER, Aug. 16, 2011 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, the European diagnostic and interventional ophthalmic device market is expected to reach over $1 billion by 2017. Growth in this market will be fueled by increases in cataract, glaucoma and refractive surgeries, particularly in Germany,...

2011-03-28 10:30:00

ABBOTT PARK, Ill., March 28, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has introduced a Micro-Implantation Cataract Suite designed to help improve cataract procedure outcomes and safety. The Micro-Implantation Cataract Suite, featured at the American Society of Cataract and Refractive Surgery Symposium and Congress in San Diego, enables the surgeon to perform an entire micro-surgical procedure, which can reduce surgically induced astigmatism, provide a safer...

2010-11-17 21:55:12

Results published in Science Translational Medicine Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine ("Femtosecond Laser-Assisted Cataract Surgery with Integrated Optical Coherence Tomography," Volume 2, Issue 58, November 17, 2010). The data showed that, when compared to manual techniques, the Catalys Precision Laser System helped...

2009-11-09 14:53:19

As many as 10 million people around the world suffer from cataracts. Thomas Kohnen of the Goethe University in Frankfurt and his coauthors discuss cataract surgery with the implantation of an artificial lens in the current issue of Deutsches Óžrzteblatt International (Dtsch Arztebl Int 2009; 106[43]: 695). Blindness is usually due to opacification of the lens. In Germany alone, more than 600,000 cataract operations are performed each year. Cataracts can be either...

2009-08-03 15:30:00

ROCHESTER, N.Y., Aug. 3 /PRNewswire/ -- Bausch & Lomb Surgical has announced the US launch of its new Akreos(R) AO Micro Incision Lens (Model MI60L). In the US, the company refers to this lens as the Akreos(R) MICS(TM) lens. This unique spherical aberration free lens has been specifically developed for 1.8 mm MICS(TM). Its award winning design and glistening free material allows implantation through a 1.8 mm incision, while maintaining the optical quality and stability first...

2009-04-03 11:53:00

WALTHAM, Mass., April 3 /PRNewswire/ -- I-Therapeutix, Inc. announced today that Mr. Richard Packard and Dr. Daniel Calladine from the Prince Charles Eye Unit, King Edward VII Hospital, Windsor, UK, performed the first ophthalmic surgeries in Europe with the company's CE Mark approved I-ZIP(R) Adherent Ocular Bandage. All phacoemulsification cataract surgeries were performed under topical anesthesia by Mr. Packard. Patients received a foldable IOL with wound-assisted implantation through a...

2009-01-12 07:01:00

ABBOTT PARK, Ill. and SANTA ANA, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Advanced Medical Optics (AMO) (NYSE: EYE) announced today a definitive agreement for Abbott to acquire AMO for $22 per share in cash, for a total transaction value of approximately $2.8 billion, inclusive of estimated net debt at the time of closing. Based in Santa Ana, Calif., AMO is a global leader in ophthalmic care, comprised of three segments: cataract surgery, laser vision correction...